Remyelination in Multiple Sclerosis: New Insights

Late in 2022, we published two new videos that provided insights on the topic of remyelination research in multiple sclerosis (MS).

The first video was recorded at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, held in Amsterdam, The Netherlands, between October 26 and 28, 2022.  In this feature, long-time MStranslate supporter and contributor, Dr Travis Stiles (CEO, Novoron Bioscience) sat down for a discussion with Associate Professor Alban Gaultier from the University of Virginia.  Referencing both their experiences at the conference and their own research work, Travis and Alban talked in-depth about the latest developments in remyelination research and the future direction of the field.

After departing The Netherlands, the MStranslate team travelled to the United Kingdom for a meeting with the Clinical MS Research Group based at the University of Cambridge.  One of the key focusses of this visit was to follow up on the unit’s research study investigating the effectiveness of metformin and clemastine to promote remyelination in people living with MS.  This work received a fantastic response when it was previously featured on MStranslate in October 2020, via a discussion between our co-founder, Brett Drummond, and Dr Will Brown (one of the lead researchers).  That video can be viewed here.  Thankfully, Will was again happy to provide an update on the progress of the work in Cambridge during our catch up.

If you have any questions on the topics discussed in these two videos, please either comment below or join the conversation on our social channels.  If we are not in a position to answer ourselves, we will seek a response directly from either Travis, Alban or Will.

Finally, as always, we thank Travis, Alban and Will for generously volunteering their time to inform both the MStranslate and broader MS communities on the work being undertaken in regards to remyelination.  An ability to repair the nerve damage caused by multiple sclerosis is the next significant step forward in MS research and care, so it is always great to hear of the positive progress being made.

Join the conversation on all things related to multiple sclerosis research by connecting with us on social media. You can find us on Facebook, Twitter, YouTube, Instagram and LinkedIn.

Learn more about the work of Novoron Bioscience here.

Learn more about the work of the Gaultier Lab here.

Learn more about the MS clinical trials being undertaken at the University of Cambridge here.